SCHEMBL8008261

SCHEMBL8008261

CCOC(=O)CN(Cc1ccc(Cl)cc1)S(=O)(=O)c1ccc(OC)cc1

nearest known ligand 0.73

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.73
TP53 P04637 1/20 0.58
MEN1 O00255 1/20 0.58
KMT2A Q03164 1/20 0.58
NPSR1 Q6W5P4 1/20 0.58
DAGLA Q9Y4D2 1/20 0.57
TAS2R14 Q9NYV8 7/20 0.57
LMNA P02545 1/20 0.55
MEP1B Q16820 1/20 0.54
CXCR3 P49682 2/20 0.54
THRB P10828 1/20 0.54
PTGES O14684 1/20 0.54
TAS2R8 Q9NYW2 1/20 0.54
CNR2 P34972 1/20 0.54
BMP1 P13497 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7350174 0.94 ALDH1A1 (0.81) ALDH1A1TAS2R14MEP1BCXCR3PTGES
SCHEMBL7003868 0.89 ALDH1A1 (0.59) ALDH1A1TP53MEN1KMT2ANPSR1
SCHEMBL5093686 0.88 ALDH1A1 (0.72) ALDH1A1TAS2R14LMNAMEP1BCXCR3
SCHEMBL8002039 0.86 DAGLA (0.76) DAGLATAS2R14MEP1BCXCR3PTGES
SCHEMBL8008258 0.85 DAGLA (0.61) ALDH1A1DAGLATAS2R14MEP1BCXCR3
SCHEMBL5577038 0.83 MEP1B (0.78) DAGLATAS2R14MEP1BTHRBBMP1
SCHEMBL22252122 0.82 KEAP1 (0.73) ALDH1A1TAS2R14LMNACXCR3PTGES
SCHEMBL7000836 0.82 BMP1 (0.69) ALDH1A1TP53TAS2R14BMP1
SCHEMBL1169298 0.80 TAS2R14 (0.88) MEN1KMT2ATAS2R14MEP1BCXCR3
SCHEMBL15772656 0.80 RORC (0.59) ALDH1A1DAGLATAS2R14MEP1BCXCR3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0845987-A4 C-PROTEINASE INHIBITORS FOR THE TREATMENT OF DISORDERS RELATED TO THE OVERPRODUCTION OF COLLAGEN FIBROGEN INC (US) 2000-05-24 EP disclosed
EP-0845987-A1 C-PROTEINASE INHIBITORS FOR THE TREATMENT OF DISORDERS RELATED TO THE OVERPRODUCTION OF COLLAGEN FIBROGEN, INC. (US) 1998-06-10 EP disclosed
WO-1997005865-A1 C-PROTEINASE INHIBITORS FOR THE TREATMENT OF DISORDERS RELATED TO THE OVERPRODUCTION OF COLLAGEN FIBROGEN, INC. (US) 1997-02-20 WO disclosed